Womens Health - SA Analysis and Market Forecasts
Summary
The Womens Health medical devices market encompasses treatments for conditions that are particular to the adult female anatomy. This includes abnormal uterine conditions, such as menorrhagia and uterine fibroids, as well as pelvic disorders such as female stress urinary incontinence. Moreover, there is a sub-segment of the female population that no longer desire to become pregnant, and seek permanent solutions to avoid conception.
In recent years, minimally invasive techniques and technologies have been developed to treat these conditions as alternatives to conventional surgery; these technologies are expected to see increased adoption in the coming years due to increased physician and patient awareness as well as an increasing number of women who are proactively seeking treatment for these embarrassing, and sometimes debilitating, conditions. However, recent lawsuits related to safety issues with some of these devices that are receiving widespread media attention, particularly in the urinary incontinence sling market, have caused some women to be skeptical of these newer technologies.
The technologies covered in this report include global endometrial devices, endometrial resection devices, uterine fibroid embolization agents, female sterilization devices, and female urinary incontinence slings. The report provides insights into the competitive landscape, the marketed and pipeline products, the current and emerging players and market analysis of the different device segments within the womens health market in Brazil. The report also provides insight into the unmet needs and an understanding of physician perceptions of the market. This report is built using data and information sourced from secondary sources and primary research interviews with leading gynecologists, urogynecologists, interventional radiologists, and general surgeons, with in-house analysis conducted by GlobalDatas team of industry experts.
*This is an on-demand report and will be delivered within 4 working days (excluding weekends) of the purchase.
Highlights
Key Questions Answered
- What is the current and future womens health market outlook in Brazil? What trends are affecting this market?
- Which are the key, high growth markets that manufacturers should expand into? Which markets are growing the fastest, and what are the top-selling products in each segment?
- What are the unmet needs with womens health devices currently on the market? How will emerging technologies fulfill these unmet needs?
- What clinical factors and technical specifications influence a physician to use one type of device over another? What is physician perception and market outlook for womens health devices?
- What are the challenges and complications that have hindered widespread adoption of newer technologies?
- With developing the next-generation of devices, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the Brazilian womens health market?
Scope
- Overview of womens health, including anatomy, epidemiology, pathophysiology, symptoms, diagnosis, and treatment guidelines and modalities.
- Annualized total womens health market revenue from 2011-2021 including adoption patterns in Brazil.
- Key topics covered include strategic competitor assessment, market characterization, identification of unmet needs, reimbursement and regulatory considerations, and implications for the womens health market.
- Pipeline analysis: Comprehensive data split across different stages of development, including a discussion of emerging trends and womens health devices in development.
- Analysis of the current and future market competition in the Brazilian womens health market. Insightful review of the key industry drivers, opportunities, barriers and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
Reasons to buy
- “What Physicians Think” quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. In this report you will understand the perceptions of leading gynecologists, urogynecologists, interventional radiologists, and general surgeons from around the world. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.
Table Of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Catalyst
2.2 Related Reports
3 Industry Overview
3.1 Overview
3.1.1 Anatomy
3.2 Indications
3.2.1 Overview
3.2.2 Abnormal Uterine Conditions
3.2.3 Female Urinary Incontinence
3.3 Clinical Presentation
3.3.1 Abnormal Uterine Conditions
3.3.2 Female Urinary Incontinence
3.4 Market Segmentation
3.5 Market Access
3.5.1 Purchasing Decisions
3.6 Influence of Clinical Trials
3.7 Adoption
3.8 Regulation
3.8.1 South America
3.9 Reimbursement
3.9.1 South America
3.10 Procedure Trends
3.10.1 By Region
3.11 Regulatory Issues/Recalls
3.11.1 Hologic Discontinues Manufacturing, Marketing, and Sales of Adiana
3.11.2 Recall of Numerous Transvaginal Mesh Products
3.12 M&As, Key Partnerships
3.12.1 Bayer Health Acquires Conceptus for $1.1 Billion
3.12.2 Boston Scientific Acquires IoGyn for $65m
3.13 Economic Impact
3.13.1 Indirect Costs
3.13.2 Direct Costs
4 Unmet Needs
4.1 Overview
4.2 Endometrial Ablation/Resection Devices
4.2.1 Better Fluid Management
4.2.2 Improved Imaging Guidance
4.2.3 Regulating Depth of Ablation
4.3 Uterine Fibroid Embolization Agents
4.3.1 Addressing Fibroid Recurrence
4.3.2 Assessing Effect on Fertility
4.3.3 Preventing Ovarian Failure
4.4 Female Sterilization Devices
4.4.1 Accelerated Scar Tissue Formation
4.4.2 Lack of Reversibility
4.4.3 Preventing Micro-insert Migration
4.4.4 Preventing Perforation
4.4.5 Trocar Size Reduction
4.5 Female Urinary Incontinence Slings
4.5.1 Anatomical Adaptation
4.5.2 Single-Incision Slings
5 Market Opportunity Analysis
5.1 Overview
5.2 Endometrial Ablation/Resection Devices
5.2.1 Targeted Fibroid Ablation
5.3 Uterine Fibroid Embolization Agents
5.3.1 Novel Agents
5.4 Female Sterilization Devices
5.4.1 Raising Patient Awareness
5.4.2 Rapid Transcervical Sterilization
5.5 Female Urinary Incontinence Slings
5.5.1 Materials and Coatings
5.5.2 European and APAC Markets
6 Market Drivers and Barriers
6.1 Endometrial Ablation/Resection
6.1.1 Driver: Patient Preference for Minimally Invasive Treatments
6.1.2 Driver: Growing Procedure Volume
6.1.3 Barrier: High Device and Procedure Cost
6.1.4 Substitute: Hysterectomy
6.1.5 Substitute: Intrauterine Devices
6.2 Uterine Fibroid Embolization Agents
6.2.1 Driver: Increasing Prevalence of Uterine Fibroids
6.2.2 Driver: Improving Imaging Capabilities
6.2.3 Barrier: Lack of Patient Awareness
6.2.4 Substitute: MRI-guided Focused Ultrasound
6.2.5 Substitute: Myomectomy
6.3 Female Sterilization Devices
6.3.1 Driver: Growing Female Population using Modern Contraception
6.3.2 Driver: Increasing Adoption of Transcervical Sterilization
6.3.3 Barrier: Patient Preference for Reversible Contraception
6.3.4 Substitute: Traditional Contraception
6.4 Female Urinary Incontinence Slings
6.4.1 Driver: Growing Treatment Rates and Use of Surgery
6.4.2 Barrier: Highly Litigious US Market
6.4.3 Substitute: Surgical Repair
6.4.4 Substitute: Pelvic Floor Electrical Stimulation
7 Competitive Assessment
7.1 Overview
7.2 Classification Based on Features
7.2.1 Endometrial Ablation Devices
7.2.2 Endometrial Resection Devices
7.2.3 Uterine Fibroid Embolization Agents
7.2.4 Female Sterilization Devices
7.2.5 Female Urinary Incontinence Slings
7.3 Key Product Profiles
7.3.1 Endometrial Ablation Devices
7.3.2 Endometrial Resection Devices
7.3.3 Uterine Fibroid Embolization Agents
7.3.4 Female Sterilization Devices
7.3.5 Female Urinary Incontinence Slings
8 Pipeline Assessment
8.1 Overview
8.2 Key Product Profiles
8.2.1 Endometrial Ablation Devices
8.2.2 Uterine Fibroid Embolization Agents
8.2.3 Female Sterilization Devices
8.2.4 Female Urinary Incontinence Slings
9 Clinical Trials to Watch
9.1 Overview
9.2 Minerva Pivotal Study to Evaluate Safety and Efficacy of the Aurora Endometrial Ablation System Compared to Hysteroscopic Rollerball Ablation
9.3 Post Market Study of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence (Solyx)
9.4 Safety & Effectiveness Study of Aegea Vapor System to Treat Excessive Uterine Bleeding
9.5 The European Study of Altis Single Incision Sling System for Female Stress Urinary Incontinence (EASY)
10 Current and Future Players
10.1 Overview
10.2 Trends in Corporate Strategy
10.3 Company Profiles
10.3.1 American Medical Systems
10.3.2 AngioDynamics
10.3.3 Bayer Healthcare (Bayer AG)
10.3.4 Boston Scientific
10.3.5 BTG
10.3.6 Coloplast
10.3.7 Cook Medical
10.3.8 CooperSurgical
10.3.9 C.R. Bard
10.3.10 Ethicon (Johnson & Johnson)
10.3.11 Femcare-Nikomed (Utah Medical Products)
10.3.12 Hologic
10.3.13 Karl Storz
10.3.14 Olympus
10.3.15 Richard Wolf
10.3.16 Stryker
11 Market Outlook
11.1 By Geography
11.1.1 By Country
12 Appendix
12.1 Bibliography
12.2 Abbreviations
12.3 Report Methodology
12.3.1 Overview
12.3.2 Coverage
12.3.3 Secondary Research
12.4 Forecasting Methodology
12.5 Physicians and Specialists Included in This Study
12.6 Primary Research - Prescriber Survey
12.7 About the Authors
12.7.1 Analysts
12.7.2 Global Head of Healthcare
12.8 About GlobalData
12.9 Disclaimer
List Of Tables
1.1 List of Tables
Table 1: Types of Uterine Fibroids
Table 2: Types of Female Urinary Incontinence
Table 3: Drug and Hormone Treatments for Menorrhagia
Table 4: Surgical Treatments for Menorrhagia
Table 5: Treatments for Stress, Urge, and Mixed Urinary Incontinence
Table 6: Market Segmentation for Women’s Health Market
Table 7: Endometrial Ablation Devices, SWOT Analysis, 2015
Table 8: Currently Marketed Endometrial Ablation Devices, 2015
Table 9: Endometrial Resection, SWOT Analysis, 2015
Table 10: Uterine Fibroid Embolization, SWOT Analysis, 2015
Table 11: Device-based Permanent Female Sterilization, SWOT Analysis, 2015
Table 12: Currently Marketed Notable Female Urinary Incontinence Slings, 2015
Table 13: Female Urinary Incontinence Slings, SWOT Analysis, 2015
Table 14: Product Profile - Cavaterm (Veldana Medical)
Table 15: Cavaterm, SWOT Analysis, 2015
Table 16: Product Profile - ThermaChoice (Ethicon)
Table 17: ThermaChoice, SWOT Analysis, 2015
Table 18: Product Profile - Genesys HTA (Boston Scientific)
Table 19: Genesys HTA, SWOT Analysis, 2015
Table 20: Product Profile - NovaSure (Hologic)
Table 21: NovaSure, SWOT Analysis, 2015
Table 22: Product Profile - Minerva Endometrial Ablation System (Minerva Surgical)
Table 23: Minerva Endometrial Ablation System, SWOT Analysis, 2015
Table 24: Product Profile - Her Option (CooperSurgical)
Table 25: Her Option, SWOT Analysis, 2015
Table 26: Product Profile - Acculis MTA (AngioDynamics)
Table 27: Acculis MTA, SWOT Analysis, 2015
Table 28: Product Profile - Acessa (Halt Medical)
Table 29: Acessa, SWOT Analysis, 2015
Table 30: Product Profile - Sonata (Gynesonics)
Table 31: Sonata, SWOT Analysis, 2015
Table 32: Product Profile - 26Fr Continuous Flow Resectoscope (Stryker)
Table 33: 26Fr Continuous Flow Resectoscope, SWOT Analysis, 2015
Table 34: Product Profile - Karl Storz Bipolar Resectoscope (Karl Storz)
Table 35: Karl Storz Bipolar Resectoscope, SWOT Analysis, 2015
Table 36: Product Profile - SurgMaster Resectoscope (Olympus)
Table 37: SurgMaster Resectoscope, SWOT Analysis, 2015
Table 38: Product Profile - Princess Resectoscope (Richard Wolf)
Table 39: Princess Resectoscope, SWOT Analysis, 2015
Table 40: Product Profile - Versapoint (Ethicon)
Table 41: Versapoint, SWOT Analysis, 2015
Table 42: Product Profile - Gelfoam (Pfizer)
Table 43: Gelfoam, SWOT Analysis, 2015
Table 44: Product Profile - Bead Block (BTG)
Table 45: Bead Block, SWOT Analysis, 2015
Table 46: Product Profile - Contour PVA Embolization Particles (Boston Scientific)
Table 47: Contour PVA Embolization Particles, SWOT Analysis, 2015
Table 48: Product Profile - PVA Foam Embolization Particles (Cook Medical)
Table 49: PVA Foam Embolization Particles, SWOT Analysis, 2015
Table 50: Product Profile - Embosphere Microspheres (Merit Medical Systems)
Table 51: Embosphere Microspheres, SWOT Analysis, 2015
Table 52: Product Profile - Filshie Clip (Femcare-Nikomed)
Table 53: Filshie Clip, SWOT Analysis, 2015
Table 54: Product Profile - Essure (Bayer Healthcare)
Table 55: Essure, SWOT Analysis, 2015
Table 56: Product Profile - Align Urethral Support System (C.R. Bard)
Table 57: Align Urethral Support System, SWOT Analysis, 2015
Table 58: Product Profile - Altis Single Incision Sling (Coloplast)
Table 59: Altis Single Incision Sling, SWOT Analysis, 2015
Table 60: Product Profile - Gynecare TVT (Ethicon)
Table 61: Gynecare TVT, SWOT Analysis, 2015
Table 62: Product Profile - MiniArc Single-Incision Sling (American Medical Systems)
Table 63: MiniArc Single-Incision Sling, SWOT Analysis, 2015
Table 64: Product Profile - Solyx (Boston Scientific)
Table 65: Solyx, SWOT Analysis, 2015
Table 66: Product Profile - Aegea Vapor System (Aegea Medical)
Table 67: Aegea Vapor System, SWOT Analysis, 2015
Table 68: Product Profile - Cryothermic Therapy (Channel Medsystems)
Table 69: Cryothermic Therapy, SWOT Analysis, 2015
Table 70: Product Profile - Biodegradable Bead
Table 71: Biodegradable Bead, SWOT Analysis, 2015
Table 72: Product Profile - FemBloc
Table 73: FemBloc, SWOT Analysis, 2015
Table 74: Product Profile - PTMC Mesh
Table 75: PTMC Mesh, SWOT Analysis, 2015
Table 76: Product Profile - sensiTVT
Table 77: sensiTVT, SWOT Analysis, 2015
Table 78: Company Profile - American Medical Systems
Table 79: American Medical Systems, SWOT Analysis, 2015
Table 80: Company Profile - AngioDynamics
Table 81: AngioDynamics, SWOT Analysis, 2015
Table 82: Company Profile - Bayer Healthcare
Table 83: Bayer Healthcare, SWOT Analysis, 2015
Table 84: Company Profile - Boston Scientific
Table 85: Boston Scientific, SWOT Analysis, 2015
Table 86: Company Profile - BTG
Table 87: BTG, SWOT Analysis, 2015
Table 88: Company Profile - Coloplast
Table 89: Coloplast, SWOT Analysis, 2015
Table 90: Company Profile - Cook Medical
Table 91: Cook Medical, SWOT Analysis, 2015
Table 92: Company Profile - CooperSurgical
Table 93: CooperSurgical, SWOT Analysis, 2015
Table 94: Company Profile - C.R. Bard
Table 95: C.R. Bard, SWOT Analysis, 2015
Table 96: Company Profile - Ethicon
Table 97: Ethicon, SWOT Analysis, 2015
Table 98: Company Profile - Femcare-Nikomed
Table 99: Femcare-Nikomed, SWOT Analysis, 2015
Table 100: Company Profile - Hologic
Table 101: Hologic, SWOT Analysis, 2015
Table 102: Company Profile - Karl Storz
Table 103: Karl Storz, SWOT Analysis, 2015
Table 104: Company Profile - Olympus
Table 105: Olympus, SWOT Analysis, 2015
Table 106: Company Profile - Richard Wolf
Table 107: Richard Wolf, SWOT Analysis, 2015
Table 108: Company Profile - Stryker
Table 109: Stryker, SWOT Analysis, 2015
Table 110: Brazil Women’s Health Market Forecast ($m) by Market Segment, 2011-2021
Table 111: Brazil Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021
Table 112: Brazil Endometrial Resection Devices Market Forecast ($m) by Market Segment, 2011-2021
Table 113: Brazil Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021
Table 114: Brazil Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021
Table 115: Brazil Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021
List Of Figures
1.2 List of Figures
Figure 1: Percentage Breakdown of Urinary Incontinence, by Type
Figure 2: Percentage of Patients with Menorrhagia Receiving Treatment, by Type
Figure 3: Percentage of Patients with Urinary Incontinence Receiving Treatment, by Type
Figure 4: Brazil Procedure Volume Forecast, Endometrial Resection, 2011-2021
Figure 5: Brazil Procedure Volume Forecast, Uterine Artery Embolization, 2011-2021
Figure 6: Brazil Procedure Volume Forecast, Female Sterilization, 2011-2021
Figure 7: Brazil Procedure Volume Forecast, Urinary Incontinence Slings, 2011-2021
Figure 8: Brazil Women’s Health Market Forecast ($m) by Segment, 2011-2021
Figure 9: Brazil Women’s Health Market Share by Market Segment, 2014 and 2021
Figure 10: Brazil Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021
Figure 11: Brazil Endometrial Ablation Market Share by Market Segment, 2014 and 2021
Figure 12: Brazil Resectoscopes Market Forecast ($m) by Market Segment, 2011-2021
Figure 13: Brazil TCRE Electrodes Market Forecast ($m) by Market Segment, 2011-2021
Figure 14: Brazil Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021
Figure 15: Brazil Uterine Fibroid Embolization Agents Market Share by Market Segment, 2014 and 2021
Figure 16: Brazil Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021
Figure 17: Brazil Female Sterilization Devices Market Share by Market Segment, 2014 and 2021
Figure 18: Brazil Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021
Figure 19: Primary Research Participants, by Country
